Browsing publications by Professor John Lunec

Newcastle AuthorsTitleYear
Nidal Boulos
Dr Michael Tilby
Professor Deborah Tweddle
Professor John Lunec
Identification and characterisation of STMN4 and ROBO2 gene involvement in neuroblastoma cell differentiation2013
Professor Deborah Tweddle
Professor John Lunec
MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-632012
Dr Swethajit Biswas
Professor John Lunec
Professor Kim Bartlett
Non-glucose metabolism in cancer cells—is it all in the fat?2012
Dr Kenneth Rankin
Professor John Lunec
Craig Gerrand
Dr Swethajit Biswas
Of Dogs and Men: Comparative Biology as a Tool for the Discovery of Novel Biomarkers and Drug Development Targets in osteosarcoma2012
Dr Christine Challen
Dr John Anderson
Professor Zofia Chrzanowska-Lightowlers
Professor Robert Lightowlers
Professor John Lunec
et al.		Recombinant human MDM2 oncoprotein shows sequence composition selectivity for binding to both RNA and DNA2012
Dr Swethajit Biswas
Dr Kenneth Rankin
Anna Long
Dr Jennifer Jackson
Dr Mark Birch
et al.		The prognostic role of MT1-MMP and HIF Isoforms in Human Osteosarcoma2012
Dr Nicholas Bown
Professor John Lunec
Professor Deborah Tweddle
A Multilocus Technique for Risk Evaluation of Patients with Neuroblastoma2011
Dr Ian Hardcastle
Alex Liu
Dr Eric Valeur
Anna Watson
Shafiq Ahmed
et al.		Isoindolinone Inhibitors of the Murine Double Minute 2 (MDM2)-p53 Protein-Protein Interaction: Structure-ActivityStudies Leading to Improved Potency2011
Dr Karim Bennaceur
Dr Catherine Drummond
Professor Jane Endicott
Professor Bernard Golding
Professor Roger Griffin
et al.		MDM2-p53 protein-protein interaction inhibitors: A-ring substituted isoindolinones2011
Dr Jane Carr-Wilkinson
Bojidar Goranov
Dr Christopher Redfern
Laura Gamble
Professor John Lunec
et al.		Outcome of the p53-mediated DNA damage response in neuroblastoma is determined by morphological subtype and MYCN expression2011
1234567891011121314151617